Abstract:Oral squamous cell carcinoma (OSCC) is one of the common types of cancer. Its progression follows a transition from oral potentially malignant disorders (OPMDs) such as oral submucous fibrosis (OSMF). Epigenetic modifiers, especially microRNAs (miRNAs), have an appreciable role in the regulation of various carcinogenic pathways which are being used as biomarkers. miRNAs may also be helpful in the differentiation of oral submucous fibrosis from oral squamous cell carcinoma. Three miRNAs, miR-221-3p, miR133a-3p, and miR-9-5p, were found differentially expressed in many cancers in the literature search supported by our preliminary database search-based screening. The literature and our functional enrichment analysis in an earlier study have reported these miRNAs to regulate carcinogenesis at various steps. In the present study, the expression of these miRNAs was examined in 34 histopathologically confirmed OSCC, 30 OSMF, and 29 control (healthy volunteers) human samples. There was a significant downregulation of miRNA-133a-3p in OSCC compared to OSMF and controls, whereas there was up-regulation in oral submucous fibrosis compared to controls. There was no significant difference in the expression of miR-221-3p between OSCC and OSMF, but an upregulation in OSCC compared to controls. miR-9-5p was also found upregulated in both OSCC and OSMF. Further, miR-133a-3p expression was negatively correlated with age, smoking, drinking status, and AJCC staging, whereas miR-9-5p expression was only positively associated with tobacco/ areca nut chewing. The ROC plots, logistic regression model generated, and the correlation between the expression of miR-9-5p and miR-133a-3p in blood and tissue suggests that these could be used as risk stratification biomarkers.

Gene Expression Profiling of Oral Submucous Fibrosis Using Oligonucleotide Microarray

Discovery of Novel Biomarkers in Oral Submucous Fibrosis by Microarray Analysis

Study on Differential miRNA in the Tissue of Oral Submucous Fibrosis

Mechanisms and markers of malignant transformation of oral submucous fibrosis

Spatial Transcriptomic and Metabolomic Landscapes of Oral Submucous Fibrosis-Derived Oral Squamous Cell Carcinoma and its Tumor Microenvironment

Cyclophilin A Was Revealed As a Candidate Marker for Human Oral Submucous Fibrosis by Proteomic Analysis.

Analysis on the Oral Submucous Fibrosis-related Gene by Cdna Chip

Genetic Susceptibility and Protein Expression of Extracellular Matrix Turnover-Related Genes in Oral Submucous Fibrosis

Etiology, pathogenesis, diagnosis and treatment of oral submucous fibrosis

Identification of a BRAF/PA28γ/MEK1 Signaling Axis and Its Role in Epithelial-Mesenchymal Transition in Oral Submucous Fibrosis

[Application of Bioinformatics Tools in Analysis of Differentially Expressed Genes in Oral Submucosal Fibrosis].

A Preliminary Microarray Assay of the Mirna Expression Signatures in Buccal Mucosa of Oral Submucous Fibrosis Patients

Expression Profile of Diagnostic Genes in Oral Submucous Fibrosis

The functional roles of microRNAs in the pathogenesis of oral submucous fibrosis

Evaluation of stromal myofibroblasts in oral submucous fibrosis and its malignant transformation: An immunohistochemical study

Differential Expression of Organic Cation Transporter 3 in Oral Submucous Fibrosis–associated Buccal Squamous Cell Carcinoma

Oral Submucous Fibrosis: Etiological Mechanism, Malignant Transformation, Therapeutic Approaches and Targets

Expression and Promoter Methylation of Wnt Inhibitory Factor-1 in the Development of Oral Submucous Fibrosis

Novel genetic biomarkers for susceptibility to oral submucous fibrosis: cytochrome P450 3A.

Gene mutation analysis of oral submucous fibrosis cancerization in Hainan Island

Study of MicroRNA (miR-221-3p, miR-133a-3p, and miR-9-5p) Expressions in Oral Submucous Fibrosis and Squamous Cell Carcinoma